Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors
2012 (English)In: Oncoimmunology, ISSN 2162-4011, Vol. 1, no 7, 1156-1158 p.Article in journal (Refereed) Published
Infiltration of plasma cells is associated with better prognosis in breast, lung and colon cancer. Immunoglobulin κ chain (IGKC) is now available as a single, robust immune marker predicting metastasis-free survival and response to chemotherapy. This will facilitate a deeper understanding of the role of the humoral immune system in cancer development.
Place, publisher, year, edition, pages
2012. Vol. 1, no 7, 1156-1158 p.
Clinical Laboratory Medicine
Research subject Pathology
IdentifiersURN: urn:nbn:se:uu:diva-189882DOI: 10.4161/onci.21653ISI: 000316279900015PubMedID: 23170262OAI: oai:DiVA.org:uu-189882DiVA: diva2:582530